<DOC>
	<DOCNO>NCT01161394</DOCNO>
	<brief_summary>Pioglitazone decrease oxidative load , inflammatory end point improve vascular reactivity obese patient dose dependent manner effect independent glucose lower effect .</brief_summary>
	<brief_title>Effect Pioglitazone Oxidative Load , Inflammatory End-Points Vascular Reactivity Obese Non-Diabetic Patients : A Dose Ranging Study</brief_title>
	<detailed_description>This single center , open label study . A total 24 obese patient recruit participate study . The study three group 8 patient . Subjects enrol group alternate recruitment . Subjects group one receive 15mg pioglitazone ; subject group two receive 30 mg pioglitazone ; subject group three receive placebo . All subject receive Pioglitazone placebo 6 week , follow 6-week observation period Pioglitazone/placebo . At baseline , week 1 , week 2 , week 4 , week 6 month 3 patient blood drawn TBARS , ortho meta-tyrosine , 9-HODE 13-HODE , NF , Ikb , TNF-a , ICAM-1 , VCAM-1 , PAI-1 , AP-1 , EGR-1 , MMP-2 , MMP-9 , TIMP , CRP-1 , E-Selectin , P-Selectin , Asymmetric dimethylarginine ( ADMA ) , PAPP-A , SAA , MCP-1 , IL-6 , ROS generation , insulin level , CRP . Post-ischemic dilation brachial artery use index endothelium-mediated vasodilation . All subject oral glucose tolerance test ( GTT ) 75gm glucose Day 0 Day 42 . Vascular reactivity assess 0 , 6 , 12 week .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>• Obese ( BMI &gt; =30 ) Age : 20 65 year age inclusive Without establish clinical coronary artery disease ( documented history myocardial infarction , typical angina exercise ECG positive ischemia angiographic evidence CAD ) Good health evidence History Physical exam Female subject must : Postmenopausal least one year Surgically incapable childbearing ( i.e . hysterectomy tubal ligation ) , capable childbearing subject , must practice acceptable method contraception . • Subject available duration study willing comply study requirement . • Diabetes Mellitus Allergy sensitivity Pioglitazone Current use Insulin therapy . Coronary event procedure ( myocardial infarction , unstable angina , coronary artery bypass , surgery coronary angioplasty ) previous four week Hepatic disease ( transaminase &gt; 3 time normal ) Renal impairment ( Creatinine clearance &lt; 50 mL/min ) History drug alcohol abuse COPD Participation concurrent clinical trial Any lifethreatening , noncardiac disease Use investigational agent therapeutic regimen within 30 day study Pregnancy nursing</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>